Addressing the treatment gap for patients with relapsed refractory primary systemic AL amyloidosis: TOURMALINE-AL1 trial results from rral Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Prof Evangelos Terpos (University of Athens, Athens, Greece) and Prof Efstathios Kastritis (University of Athens, Athens, Greece) discuss the treatment landscape for patients with relapsed/refractory primary systemic AL amyloidosis (RRAL).nnProf Kastritis gives an overview of this rare disease type including the challenges associated with the diagnosis, treatment and prognosis of these patients. He explains that these patients typically experience co-morbidities including cardiac dysfunction, wh
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)